To this end, a GH3 pituitary cell model stimulated with 17β-estradiol and a metoclopramide (MCP)-induced hyperprolactinemia mouse model were used, and the effects on prolactin, inflammatory cytokines, prostaglandins, and gut microbiota composition were assessed. This evidence concerns the gene PRL and hyperprolactinemia.